Technology News and Research

RSS
Excelitas Technologies announces launch of X-Cite 120LEDmini for fluorescence illumination solutions

Excelitas Technologies announces launch of X-Cite 120LEDmini for fluorescence illumination solutions

Leading researchers to gather at international nanotechnology conference in Birmingham

Leading researchers to gather at international nanotechnology conference in Birmingham

Guardian Research Network, Molecular Health to provide therapeutic clinical trial access to cancer patients

Guardian Research Network, Molecular Health to provide therapeutic clinical trial access to cancer patients

PDA extends support to Johnson & Johnson Kilmer Conference on sterility assurance and sterilization

PDA extends support to Johnson & Johnson Kilmer Conference on sterility assurance and sterilization

Transportation Insight receives SDCE100 Award for second consecutive year

Transportation Insight receives SDCE100 Award for second consecutive year

Can-Fite BioPharma reports Q1 2015 financial results, provides updates on drug development programs

Can-Fite BioPharma reports Q1 2015 financial results, provides updates on drug development programs

Federal funding constraints may jeopardize nation's research enterprise, undermine patient care

Federal funding constraints may jeopardize nation's research enterprise, undermine patient care

Maetrics, Medical Cluster host innovative conference in Zurich, Switzerland

Maetrics, Medical Cluster host innovative conference in Zurich, Switzerland

Larger studies needed to validate multigene testing for prediction of breast cancer risk

Larger studies needed to validate multigene testing for prediction of breast cancer risk

RI-MUHC researchers receive $1.5 million to develop glutamate biosensor platform for brain diseases

RI-MUHC researchers receive $1.5 million to develop glutamate biosensor platform for brain diseases

DNA analysis reveals how ovarian cancer takes genetic twists and turns to outsmart chemotherapy

DNA analysis reveals how ovarian cancer takes genetic twists and turns to outsmart chemotherapy

RPCI researchers develop individualized post-operative survival calculator for colon cancer patients

RPCI researchers develop individualized post-operative survival calculator for colon cancer patients

ACMG unveils new online educational portal focusing on genetics and genomic medicine

ACMG unveils new online educational portal focusing on genetics and genomic medicine

PDS Biotechnology announces positive results from PDS0101 Phase I trial in pre-cervical cancer patients

PDS Biotechnology announces positive results from PDS0101 Phase I trial in pre-cervical cancer patients

Amway releases BodyKey by Nutrilite tool that uses genetic test to determine weight management approach

Amway releases BodyKey by Nutrilite tool that uses genetic test to determine weight management approach

ClearDATA closes $25 million Series C funding round

ClearDATA closes $25 million Series C funding round

SurgiQuest receives FDA clearance for AirSeal System for Transanal Endoscopic Surgery

SurgiQuest receives FDA clearance for AirSeal System for Transanal Endoscopic Surgery

New Frost & Sullivan analysis finds that over 50% of health providers lack healthcare IT roadmap

New Frost & Sullivan analysis finds that over 50% of health providers lack healthcare IT roadmap

Data supporting anti-cancer potential of Biscayne’s GHRH antagonist to be discussed at ASCO Annual Meeting

Data supporting anti-cancer potential of Biscayne’s GHRH antagonist to be discussed at ASCO Annual Meeting

Envision to conduct Assistive Technology Camps for blind or visually impaired students

Envision to conduct Assistive Technology Camps for blind or visually impaired students

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.